Literature DB >> 5144742

Studies on flavonoid metabolism. Biliary and urinary excretion of metabolites of (+)-(U- 14 C)catechin.

N P Das, S P Sothy.   

Abstract

1. The biliary and urinary excretion of (+)-[U-(14)C]catechin was studied in normal male rats after a single injection of the flavonoid. 2. In rats large amounts of radioactivity (33.6-44.3% of the dose in 24h) were excreted in the bile as two glucuronide conjugates [one of which was a (+)-catechin conjugate] and three other unconjugated metabolites. 3. Excretion of radioactivity in the urine when the bile duct was not cannulated amounted to 44.5% of the dose. 4. In both the urine and bile the new metabolites showed maximum excretion in the (1/2)-1(1/2)h after intravenous injection of [(14)C]catechin. 5. The metabolites m-hydroxyphenylpropionic acid, p-hydroxyphenylpropionic acid, delta-(3-hydroxyphenyl)-gamma-valerolactone and delta-(3,4-dihydroxyphenyl)-gamma-valerolactione originate from the action of the intestinal micro-organisms on the biliary-excreted metabolites of (+)-catechin. These phenolic acid and lactone metabolites are then reabsorped and excreted in the urine. 6. It is proposed that, depending on the route of administration of (+)-catechin, there exists an alternative pathway, involving biliary excretion, for the metabolism of (+)-catechin.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5144742      PMCID: PMC1178075          DOI: 10.1042/bj1250417

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Metabolic fate of hesperidin, eriodictyol, homoeridictyol, and diosmin.

Authors:  A N BOOTH; F T JONES; F DeEDS
Journal:  J Biol Chem       Date:  1958-02       Impact factor: 5.157

2.  Metabolic and glucosuria studies on naringin and phloridzin.

Authors:  A N BOOTH; F T JONES; F DEEDS
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

3.  The metabolic fate of rutin and quercetin in the animal body.

Authors:  A N BOOTH; F DEEDS; F T JONES; C W MURRAY
Journal:  J Biol Chem       Date:  1956-11       Impact factor: 5.157

4.  Distribution and fate of morphine in non-tolerant and tolerant dogs and rats.

Authors:  L A WOODS
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

5.  Studies on flavonoid metabolism. Metabolism of flavone in the guinea pig.

Authors:  N P Das; L A Griffiths
Journal:  Biochem J       Date:  1966-02       Impact factor: 3.857

6.  Differences between the biliary excretion of tri [14C] methyl-(3-hydroxy-phenyl) ammonium iodide in Wistar and Gunn rats.

Authors:  T N Calvey; S M Somani; A Wright
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  Studies on flavonoid metabolism. Biosynthesis of (+)-[14C]catechin by the plant Uncaria gambir Roxb.

Authors:  N P Das; L A Griffiths
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

8.  Steroid metabolism in the cat. Biliary and urinary excretion of metabolites of [4-14C] oestradiol.

Authors:  M F Karim; W Taylor
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

9.  Studies on flavonoid metabolism. Metabolism of (+)-catechin in the guinea pig.

Authors:  N P Das; L A Griffiths
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

10.  Studies on phenolic steroids in human subjects. II. The metabolic fate and hepato-biliary-enteric circulation of C14-estrone and C14-estradiol in women.

Authors:  A A SANDBERG; W R SLAUNWHITE
Journal:  J Clin Invest       Date:  1957-08       Impact factor: 14.808

View more
  10 in total

1.  Metabolism of flavonoid compounds in germ-free rats.

Authors:  L A Griffiths; A Barrow
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

2.  Disposition of quercetin in man after single oral and intravenous doses.

Authors:  R Gugler; M Leschik; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  (+)-Cyanidanol-3 as inhibitor of prostaglandin synthetase. Studies on renal medulla and liver of the rat in vitro and in vivo.

Authors:  J Baumann; F von Bruchhausen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

4.  A structure-activity study on the influence of phenolic compounds and bioflavonoids on rat renal prostaglandin synthetase.

Authors:  J Baumann; F von Bruchhausen; G Wurm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

5.  The bacterial degradation of flavonoids. Oxidative fission of the A-ring of dihydrogossypetin by a Pseudomonas sp.

Authors:  A M Jeffrey; D M Jerina; R Self; W C Evans
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

6.  Protection of mice against endotoxin-induced liver damage by anti-inflammatory drugs.

Authors:  J Ferluga; A Kaplun; A C Allison
Journal:  Agents Actions       Date:  1979-12

7.  Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro.

Authors:  L A Griffiths; G E Smith
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

8.  Catabolism of phenylpropionic acid and its 3-hydroxy derivative by Escherichia coli.

Authors:  R Burlingame; P J Chapman
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

9.  The disposition of 3-O-methyl-(+)-catechin in the rat and the marmoset following oral administration.

Authors:  A M Hackett; L A Griffiths
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

10.  Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trial.

Authors:  J C Colman; M Y Morgan; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.